BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 59 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2022. The put-call ratio across all filers is 2.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $427,917 | +1760.5% | 149,100 | +965.0% | 0.00% | – |
| Q3 2022 | $23,000 | -37.8% | 14,000 | -5.4% | 0.00% | – |
| Q2 2022 | $37,000 | -32.7% | 14,800 | -25.6% | 0.00% | – |
| Q1 2022 | $55,000 | -29.5% | 19,900 | +35.4% | 0.00% | -100.0% |
| Q4 2021 | $78,000 | -38.1% | 14,700 | -1.3% | 0.00% | 0.0% |
| Q3 2021 | $126,000 | -63.7% | 14,900 | -47.7% | 0.00% | -75.0% |
| Q2 2021 | $347,000 | -67.5% | 28,500 | -14.4% | 0.00% | -71.4% |
| Q4 2020 | $1,068,000 | +337.7% | 33,313 | +311.3% | 0.01% | +180.0% |
| Q3 2020 | $244,000 | – | 8,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $104,289,000 | 4.42% |
| Boxer Capital, LLC | 2,014,858 | $60,909,000 | 2.10% |
| RA Capital Management | 2,589,904 | $78,293,000 | 1.43% |
| Artal Group S.A. | 1,521,517 | $45,995,000 | 1.12% |
| Ikarian Capital, LLC | 358,941 | $10,851,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $24,260,000 | 0.59% |
| Bellevue Group AG | 1,403,000 | $42,413,000 | 0.59% |
| Logos Global Management LP | 123,465 | $3,732,000 | 0.48% |
| Casdin Capital, LLC | 289,395 | $8,748,000 | 0.39% |
| HighVista Strategies LLC | 16,391 | $496,000 | 0.36% |